17954-11-9

Basic information

• Product Name: 2-(3-BROMOPROPOXY)BENZALDEHYDE
• Synonyms: 2-(3-BROMOPROPOXY)BENZALDEHYDE;NSC 84067
• CAS NO: 17954-11-9
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.1
• Mol File: 17954-11-9.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 344.1 °C at 760 mmHg
• Flash Point: 161.9 °C
• Appearance: /
• Density: 1.419 g/cm³
• Vapor Pressure: 6.75E-05mmHg at 25°C
• Refractive Index: 1.575
• CAS DataBase Reference: 2-(3-BROMOPROPOXY)BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-BROMOPROPOXY)BENZALDEHYDE(17954-11-9)
• EPA Substance Registry System: 2-(3-BROMOPROPOXY)BENZALDEHYDE(17954-11-9)

Safety Data

• Hazardous Substances Data: 17954-11-9(Hazardous Substances Data)

Usage

General Description

2-(3-Bromopropoxy)benzaldehyde is a chemical compound consisting of a benzaldehyde molecule that is attached to a 3-bromopropoxy group. It is used as an intermediate in the production of pharmaceuticals, agrochemicals, and other organic compounds. This chemical is commonly used in the synthesis of various organic compounds due to its versatile chemical reactivity and functional groups. The 3-bromopropoxy group provides a site for further chemical reactions and modifications, making this compound useful in the development of new molecules for various applications in the pharmaceutical and chemical industries.

InChI:InChI=1/C10H11BrO2/c11-6-3-7-13-10-5-2-1-4-9(10)8-12/h1-2,4-5,8H,3,6-7H2

Upstream product

• 89-95-2 2-methyl-benzyl alcohol 
• 109-64-8 1,3-dibromo-propane 
• 90-02-8 salicylaldehyde 

Downstream Products

• 247114-48-3 2-[3-(1H-imidazol-2-ylsulfanyl)-propoxy]-benzaldehyde 
• 247114-46-1 2-[3-(1H-benzoimidazol-2-ylsulfanyl)-propoxy]-benzaldehyde 
• 1428269-52-6 C₂₂H₂₄N₂O₇ 
• 1184723-02-1 2-[3-(nitrooxy)propoxy]benzoic acid 
• 97384-45-7 2-(3-bromopropyloxy)benzoic acid 
• 1378999-58-6 2',3',4'-tri-O-benzyl-6'-O-[2-(3-bromopropoxy)benzoyl]-α-D-methylglucoside 
• 141534-60-3 3-(2-formylphenoxy)propyl nitrate 

Relevant articles and documents

A switch-on MRI contrast agent for noninvasive visualization of methylmercury

This communication presents the first Gd(iii)-based T1 MRI contrast agent, o-MeHgGad, for noninvasive visualization of CH3Hg+. o-MeHgGad showed a relaxivity enhancement of 62% in the presence of 1 equiv. of CH3Hg+. Moreover, a noticeable contrast enhancement was recorded in the liver, kidney, and intestine of mice exposed to CH3Hg+. Thus, the newly designed contrast agent has the potential to be used for in vivo bio-imaging of CH3Hg+ and could be useful for biomedical applications.

Site-Selective Conversion of Azido Groups at Carbonyl α-Positions to Diazo Groups in Diazido and Triazido Compounds

This paper reports on the selective conversion of alkyl azido groups at the carbonyl α-position to diazo compounds. Through β-elimination of dinitrogen, followed by hydrazone formation/decomposition, α-azidocarbonyl moieties were transformed into α-diazo carbonyl groups in one step. As these reaction conditions do not involve aryl or general alkyl azides, site-selective conversions of di- and triazides were achieved. Through this method, the successive site-selective conjugation of the triazido molecule with three different components is demonstrated.

Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents

A series of novel nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide were designed, synthesized and evaluated as potential antiplatelet agents. Compound 10b significantly inhibited the adenosine diphosphate (ADP)-induced platelet aggregation